Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24525N0115
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, through Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. on October 9, 2024, for Jynarque (tolvaptan) 90mg-30mg with a ceiling value of $12,559.90. This firm-fixed-price delivery order, with an ultimate completion date of October 11, 2024, will be performed in Pittsburgh, Pennsylvania. The award carries no set-aside designation, reflecting Otsuka's status as an established pharmaceutical manufacturer within the federal contracting system.
This delivery order is issued under Otsuka's Blanket Purchase Agreement for Jynarque, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The BPA, valued at $83.3 million with a completion date of March 26, 2026, was awarded by the VA's National Acquisition Center under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This delivery order supports the VA's mission to provide specialized pharmaceutical treatments to veterans across multiple integrated service networks, with Jynarque representing one of Otsuka's primary federal contract deliverables to the Veterans Health Administration.
Quick answers
Who was awarded contract 36C24525N0115?
36C24525N0115 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 9, 2024.
How much is contract 36C24525N0115 worth?
The government has obligated $12,560 on 36C24525N0115.
Is contract 36C24525N0115 an order under another contract?
Yes. 36C24525N0115 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0115 competed?
The extent of competition for 36C24525N0115 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award